AIDS and HIV Therapy

Early Recombinant Interleukin-12 Treatment May Provide Protection

Published in AIDS Weekly, February 4th, 2002

by Michael Greer, senior medical writer - Early administration of recombinant interleukin-12 can protect macaques from the simian version of HIV, according to researchers in the United States.

Dr. Aftab A. Ansari and colleagues at Emory University School of Medicine in Atlanta assessed the benefits of "recombinant rhesus interleukin-12 (rMamu-IL-12) administration during acute simian immunodeficiency virus SIV_mac 251 infection" in their study, published in the February 2002 edition of the Journal of Virology.

High doses of the recombinant cytokine enabled treated animals to survive SIV infection, Ansari and coauthors found.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2002-02-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry